Yoshinori Kato, PhD is an expert in Biochemistry at Hoshi University (Japan). Yoshinori Kato has authored 47 publications, the most recent in 2025. SLR score: 131 (community average: 125). How the SLR is computed.

LeadR Profile

Yoshinori Kato, PhD Hoshi University Japan
131 ScienceLeadR Reputation 131
Network Map

Biochemistry

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2002 - 2025

Source: PubMed

Hoshi University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 47

Citations

Citations: 2 005 1st author: 13 Last author: 7 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Microfibril-Associated Protein 5 Contributes to the Elastic Fiber Abnormalities in Aged Skin.
PMID 40268468 — skin, genes, microfibrils, biochemistry, aging, dermis, aged, pharmacology, toxicology, fibroblasts, tissues
Biol Pharm Bull20250
Designing the Arginine-Depleting Enzyme for Tumor Targeting.
PMID 39950605 — arginine, pharmaceutical preparations, amino acids, neoplasms, enzymes, therapeutics, lysine
Mol Pharm20250
Corrigendum to "Structure-function studies of the bHLH phosphorylation domain of TWIST1 in prostate cancer cells" [Neoplasia 17 (2014) 85].
PMID 39389677 — cells, neoplasms, prostate, prostatic neoplasms
Neoplasia20240
Blood endocan as a biomarker for breast cancer recurrence.
PMID 39331092 — blood, breast neoplasms, neoplasms, biomarkers, breast
Cancer Biomark20240
COL8A1 facilitates the growth of triple-negative breast cancer via FAK/Src activation.
PMID 35624176 — growth, triple negative breast neoplasms, neoplasm metastasis, cells, hypoxia, cell line, genes, src
Breast Cancer Res Treat202216

LeadR Networks

Main global connection map